New Times,
New Thinking.

Clegg ahead in first post-debate polls

Lib Dem leader the big winner according to pollsters but what was your verdict?

By George Eaton

It’s always wise to be wary of instant reaction polls but tonight they’re all pointing to one conclusion: Nick Clegg won the first leaders’ debate.

Gordon Brown held his own tonight (there was no “car-crash moment”) so Labour will be disappointed that he’s a distant third in two of the three polls. But given how poor his personal ratings were to start with, that’s probably no surprise.

Here are the figures:

YouGov/Sun poll

Select and enter your email address Your weekly guide to the best writing on ideas, politics, books and culture every Saturday. The best way to sign up for The Saturday Read is via saturdayread.substack.com The New Statesman's quick and essential guide to the news and politics of the day. The best way to sign up for Morning Call is via morningcall.substack.com
Visit our privacy Policy for more information about our services, how Progressive Media Investments may use, process and share your personal data, including information on your rights in respect of your personal data and how you can unsubscribe from future marketing communications.
THANK YOU

Brown 19%
Cameron 29%
Clegg 51%

ComRes/ITV News poll: Who won the debate?

Brown 20%
Cameron 26%
Clegg 43%

Which party leader would you say you trust most to make any necessary cuts to public services?

Brown 28%
Cameron 36%
Clegg 36%

Which one of the three main parties do you think has the best policies on immigration?

Conservative 37%
Labour 20%
Lib Dem 35%

Final Sky News poll

Brown 32%
Cameron 31%
Clegg 37%

UPDATE: Clegg also leads in two more post-debate polls.

Angus Reid

Brown 19%
Cameron 21%
Clegg 46%

Populus/Times

Brown 17%
Cameron 22%
Clegg 61%

 

Follow the New Statesman team on Facebook.

Content from our partners
Unlocking investment in UK life sciences through manufacturing
Data defines a new era for fundraising
A prescription for success: improving the UK's access to new medicines